A study to investigate the efficacy and safety of selepressin as treatment for patients with septic shock that need vasopressor treatment

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003973-41

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate superiority of selepressin plus standard care versus placebo plus standard care in the number of vasopressor- and mechanical ventilator-free days (with penalty for mortality) in patients with vasopressor-dependent septic shock


Critère d'inclusion

  • Vasopressor-dependent Septic Shock